Prof Pascal Thomas — Top 1% Thoracic Neoplasms

Prof Pascal Thomas is an expert in Surgery at Hôpital Nord (France). As of October 2026, ScienceLeadR ranks Pascal Thomas in the top 1% of experts worldwide for Thoracic Neoplasms and Lung Neoplasms. Pascal Thomas has authored 349 publications, the most recent in 2026, and is an investigator in 14 clinical trials, 3 of them ongoing. SLR score: 996 (community average: 125). How the SLR is computed.

Surgery

Subspecialties: Thoracic And Cardiovascular Surgery - Oncology - Pulmonology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on October 6, 2026

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2002 - 2026

Source: PubMed

Aix-Marseille University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 349

Citations

Citations: 11 991 1st author: 15 Last author: 69 Unique author: 15

Main journals

Eur J Cardiothorac Surg 75

Ann Thorac Surg 22

J Thorac Cardiovasc Surg 15

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title	Journal	Year
CT radiomics-histopathological correlation for mediastinal lymph node staging in non-small cell lung cancer. PMID 42672068 — cells, lung, lymph nodes, neoplasms, carcinoma, non-small-cell lung, lung neoplasms, lymph, small cell lung carcinoma	PLoS One	2026
Impact of CGA and Surgical Risk Calculator before elective cancer surgery on postoperative delirium in elderly patients. PMID 42258005 — delirium, neoplasms, aged, palliative care	Support Care Cancer	2026
Correction: Prisciandaro et al. Anatomical Versus Non-Anatomical Pulmonary Metastasectomy: European Multicentre Analysis. Cancers 2026, 18, 1037. PMID 42193035 — metastasectomy	Cancers (Basel)	2026
Clustering by patients-related characteristics identifies specific phenotypes with different prognosis after resection of non-small cell lung cancer: a French nationwide study from the Epithor database. PMID 41997853 — cells, mortality, lung, neoplasms, phenotype, carcinoma, non-small-cell lung, lung neoplasms, small cell lung carcinoma, cluster analysis, therapeutics, prognosis	Thorax	2026
French organ procurement organisation agence de la biomédecine 2024 report for lung transplantation. PMID 41903442 — lung, emphysema, transplants, lung diseases, lung transplantation, bronchiectasis, transplantation	Respir Med Res	2026

Clinical Studies 14

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 10

Phase 3 4

By status:

Completed 7

Recruiting 3

Terminated 3

Unknown 1

By type:

Interventional 11

Observational 3

By Monocentric/Multicentric:

monocentric 5

multicentric2to4 1

multicentric5to9 0

multicentricup10 8

Main Topics

Respiratory Tract Diseases 5

Digestive System Diseases 3

Cohort/Consortium Investigators 3

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study	Phase	Status	Start
Veno arterial ExtraCorporeal Membrane Oxygenation to Reduce Morbidity and Mortality Following Lung TransPlant NCT05664204 — mortality, lung, extracorporeal membrane oxygenation, drug-related side effects and adverse reactions, transplants, morbidity, ventilation, membranes	N/A	Recruiting	2024
Randomized Multicenter Phase III Trial to Assess Conformal Post operative Radiotherapy vs Surveillance After Complete Resection of Stage II III Thymoma (RADIO RYTHMIC 01) NCT04731610 — radiotherapy, thymoma	N/A	Recruiting	2021
Molecular Signature From Tumor to Lymph Nodes NCT04677205 — lung, lymph nodes, neoplasms, carcinoma, non-small-cell lung, drug therapy, lung neoplasms, lymph, tissues, prognosis, chemotherapy	N/A	Recruiting	2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS

Shopping Cart

System Maintenance Notice

Pascal Thomas